Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes.
Publication
, Journal Article
Ortel, TL; Neal, MC; Thames, EH; Moore, KD; Navalta, LA; Lawson, JH
Published in: Blood
November 15, 1997
Duke Scholars
Published In
Blood
ISSN
0006-4971
Publication Date
November 15, 1997
Volume
90
Issue
10
Start / End Page
2083 / 2083
Publisher
W B SAUNDERS CO
Related Subject Headings
- Immunology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ortel, T. L., Neal, M. C., Thames, E. H., Moore, K. D., Navalta, L. A., & Lawson, J. H. (1997). Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes. Blood, 90(10), 2083–2083.
Ortel, T. L., M. C. Neal, E. H. Thames, K. D. Moore, L. A. Navalta, and J. H. Lawson. “Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes.” Blood 90, no. 10 (November 15, 1997): 2083–2083.
Ortel TL, Neal MC, Thames EH, Moore KD, Navalta LA, Lawson JH. Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes. Blood. 1997 Nov 15;90(10):2083–2083.
Ortel, T. L., et al. “Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes.” Blood, vol. 90, no. 10, W B SAUNDERS CO, Nov. 1997, pp. 2083–2083.
Ortel TL, Neal MC, Thames EH, Moore KD, Navalta LA, Lawson JH. Inhibitor development after surgical exposure to bovine thrombin: Antibody spectrum and clinical outcomes. Blood. W B SAUNDERS CO; 1997 Nov 15;90(10):2083–2083.
Published In
Blood
ISSN
0006-4971
Publication Date
November 15, 1997
Volume
90
Issue
10
Start / End Page
2083 / 2083
Publisher
W B SAUNDERS CO
Related Subject Headings
- Immunology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology